KILROY REALTY REIT CORP (KRC)
Sector: Real Estate
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Real Estate
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for KRC
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| KRC | Independent Director; Chair | 74 | ["over 30 years of executive and board experience with both public and private companies in the health sciences and medical industries","Chair of the Board of Green Ninja","Acting CEO and director of Abram Scientific from 2015 to 2022","Chief Integration Officer of ITC Nexus Holding Company","President and Chief Operating Officer of CryoCor, Inc.","Managing Partner of Perennial Ventures","Vice President at Tredegar Investments","Various Scientific and Executive Positions with Syntex, Inc., UroSystems, Inc., Medtronic Inc., DepoMed Systems, Inc., and CardioGenesis Corp.","Former member of the Board of Trustees of Goucher College","holds Bachelor’s degrees in Biology and Chemistry and a PhD in Biology from the University of California, Santa Cruz","High level of financial and accounting expertise","Executive leadership experience","Risk management experience","Investment experience"] | ["Compensation","Audit (Chair)","Audit Committee"] | 2026 |
Biography sourced from the proxy statement filing.
Dr. Brennan was nominated to serve on the Board because of his over 30 years of executive and board experience with both public and private companies in the health sciences and medical industries, which are target tenants of the Company s life sciences portfolio. Dr. Brennan provides the Board with vital insight into the needs of life sciences tenants, as well as deep expertise in executive and board matters. Career Highlights: Chair of the Board of Green Ninja, a science focused, project-based learning curriculum. Acting CEO and director of Abram Scientific, a privately held medical diagnostics company, from 2015 to 2022. Chief Integration Officer of ITC Nexus Holding Company, a medical diagnostics company, following the merger of Nexus and International Technidyne Corporation in 2011, and CEO of Nexus Dx, Inc. from 2011 to 2014. President and Chief Operating Officer of CryoCor, Inc. (CryoCor, formerly Nasdaq: CRYO) from 2005 to 2006 and Chief Executive Officer from 2006 until 2008, when the company was sold to Boston Scientific Corporation. Managing Partner of Perennial Ventures, a Seattle-based venture capital firm, from 2001 to 2004. Vice President at Tredegar Investments from 2000 to 2001. Various Scientific and Executive Positions with Syntex, Inc., UroSystems, Inc., Medtronic Inc., DepoMed Systems, Inc., and CardioGenesis Corp. prior to 2000. Former member of the Board of Trustees of Goucher College and current member of the boards of directors of several private companies, including TargetDX Laboratory. Holds Bachelor s degrees in Biology and Chemistry and a PhD in Biology from the University of California, Santa Cruz. Other Public Company Boards: Member of the board of directors of HemoSense, Inc. (HemoSense, formerly NYSE: HEM) from 2000 and Chairman of HemoSense from 2004 until its sale to Inverness Medical Innovations in 2007. Member of the board of directors of CryoCor from 2006 until its sale to Boston Scientific Corporation in 2008.